JPM, the industrys largest healthcare investment symposium, provides a detailed look at the state of the industry today and where it is headed in the coming year. This invite-only event brings together global industry leaders, emerging fast-growth companies, technology creators, and members of the investment community to discuss the latest market trends and innovations.<\/p>\n
Citeline will provide daily updates and insights from JPM24. Those who register<\/a> for updates will receive a top-level summary (via Scrip) and a detailed breakdown of what was announced in each companys presentations (via Biomedtracker).<\/p>\n Key industry experts from Citeline attending JPM include analysts and reporters from Citelines Scrip and Biomedtracker publications. Further Citeline coverage will also be provided by journalists from Medtech Insight.<\/p>\n Following the conference, Citeline will host a webinar with a panel of industry experts to discuss key JPM takeaways with an outlook for 2024. The webinar will take place Feb. 6.<\/p>\n Sign up<\/a> for access to Citelines JPM updates. For access to Scrip and Biomedtracker, visit Citeline<\/a>.<\/p>\n About Citeline <\/strong> Citelines global teams of analysts, journalists, and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts, and more. For more information on one of the worlds most trusted health science partners, visit\u00a0Citeline<\/u><\/a> and follow on LinkedIn<\/a> and X (formerly Twitter)<\/a>.<\/p>\n Citeline PR contact:<\/strong>\u00a0
Citeline, a Norstella<\/a> company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.\u00a0\u00a0<\/p>\n
Diffusion PR for Citeline
citeline@diffusionpr.com<\/u><\/a>\u00a0
(213) 318-4500<\/p>\n
![](\"https:\/\/ml.globenewswire.com\/media\/OGI4Yjc5YmItMjU4NS00YzQwLWFiZDItNTQwMGFhY2U2NjM3LTEwNDA3ODM=\/tiny\/Caerus-Us-1-Inc-dba-Citeline-.png\")
![\"Primary](\"https:\/\/ml.globenewswire.com\/media\/3f555b28-36ad-4f4d-8c8a-b0107d18e558\/small\/citeline-logo-full-colour-rgb-png.png\"){kind=logo}
<\/a><\/p>\n